XU Liangyun, ZHANG Qigang, FAN Guanglai, ZHAO Jianhua. Establishment of fluorescent quantitative polymerase chain reaction detection method for human parvovirus B19[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 11-14, 20. DOI: 10.7619/jcmp.20210246
Citation: XU Liangyun, ZHANG Qigang, FAN Guanglai, ZHAO Jianhua. Establishment of fluorescent quantitative polymerase chain reaction detection method for human parvovirus B19[J]. Journal of Clinical Medicine in Practice, 2021, 25(7): 11-14, 20. DOI: 10.7619/jcmp.20210246

Establishment of fluorescent quantitative polymerase chain reaction detection method for human parvovirus B19

More Information
  • Received Date: January 12, 2021
  • Available Online: April 20, 2021
  • Published Date: July 27, 2021
  •   Objective  To establish a fluorescent quantitative polymerase chain reaction detection method (PCR) method for simultaneous detection of human parvovirus B19(HPV B19).
      Methods  The online tool MAFFT was used to compare and analyze the sequence NS1 gene conserved region of three genotypes HPV B19, and specific primers and probes were designed for conserved region sequences. The fluorescent quantitative PCR method for detecting HPV B19 was established, and the sensitivity and specificity of the method were evaluated.
      Results  A standard curve drawn with a plasmid DNA template at a concentration of 1×107 to 1×102 copies/μL and 20 copies/μL, the reaction efficiency E was 0.946 and R2 was 0.996 6; the detection limit of this method was 10 copies/μL and the lower limit of quantification was 20 copies/μL. Herpes simplex virus (HSV) type 2, cytomegalovirus (CMV), group B streptococcus (GBS), hepatitis B virus (HBV), Epstein-Barr virus (EBV) positive DNA virus test results were negative, and the reference plasmid and HPV B19 positive samples were amplified.
      Conclusion  The established fluorescent quantitative PCR detection method can be applied for the screening and diagnosis of HPV B19 infection as high sensitivity and specificity.
  • [1]
    PAVER W K, CAUL E O, CLARKE S K. Letter: Parvovirus-like particles in human sera[J]. Lancet, 1975, 1(7900): 232-232. http://europepmc.org/abstract/med/46024
    [2]
    WALDMAN M, KOPP J B. Parvovirus B19 and the kidney[J]. Clin J Am Soc Nephrol, 2007, 2(Suppl 1): S47-S56. http://www.ncbi.nlm.nih.gov/pubmed/17699510
    [3]
    KAHN J S, KESEBIR D, COTMORE S F, et al. Seroepidemiology of human bocavirus defined using recombinant virus-like particles[J]. J Infect Dis, 2008, 198(1): 41-50. doi: 10.1086/588674
    [4]
    DE JONG E P, WALTHER F J, KROES A C M, et al. Parvovirus B19 infection in pregnancy: new insights and management[J]. Prenat Diagn, 2011, 31(5): 419-425. doi: 10.1002/pd.2714
    [5]
    ROGO L D, MOKHTARI-AZAD T, KABIR M H, et al. Human parvovirus B19: a review[J]. Acta Virol, 2014, 58(3): 199-213. doi: 10.4149/av_2014_03_199
    [6]
    罗青清, 骆名恋, 邹丽. "妊娠期微小病毒B19感染的临床实践指南"解读[J]. 中国实用妇科与产科杂志, 2016, 32(6): 502-504. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201606004.htm
    [7]
    VALEUR-JENSEN A K, PEDERSEN C B, WESTERGAARD T, et al. Risk factors for parvovirus B19 infection in pregnancy[J]. JAMA, 1999, 281(12): 1099-1105. doi: 10.1001/jama.281.12.1099
    [8]
    HARGER J H, ADLER S P, KOCH W C, et al. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms[J]. Obstet Gynecol, 1998, 91(3): 413-420. doi: 10.1016/S0029-7844(97)00701-1
    [9]
    ZHOU Y, BIAN G H, ZHOU Q X, et al. Detection of cytomegalovirus, human parvovirus B19, and Herpes simplex virus-1/2 in women with first-trimester spontaneous abortions[J]. J Med Virol, 2015, 87(10): 1749-1753. doi: 10.1002/jmv.24218
    [10]
    杨忠心, 何惠君, 代方, 等. 无偿献血员血清人微小病毒B19感染情况调查[J]. 华中科技大学学报: 医学版, 2003, 32(3): 344-345. doi: 10.3870/j.issn.1672-0741.2003.03.035
    [11]
    JIA J T, MA Y Y, ZHAO X, et al. Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives[J]. Virol J, 2015, 12: 162-162. doi: 10.1186/s12985-015-0396-z
    [12]
    BREDL S, PLENTZ A, WENZEL J J, et al. False-negative serology in patients with acute parvovirus B19 infection[J]. J Clin Virol, 2011, 51(2): 115-120. doi: 10.1016/j.jcv.2011.03.012
    [13]
    JIA J T, ZHONG Y D, GUO Y, et al. Simultaneous detection and differentiation of human parvovirus B19 and human parvovirus 4 by an internally controlled multiplex quantitative real-time PCR[J]. Mol Cell Probes, 2017, 36: 50-57. doi: 10.1016/j.mcp.2017.08.005
    [14]
    ALVES A D R, CUBEL GARCIA R C N, CRUZ O G, et al. Quantitative real-time PCR for differential diagnostics of parvovirus B19 infection in acute liver failure patients[J]. Expert Rev Mol Diagn, 2019, 19(3): 259-266. doi: 10.1080/14737159.2019.1582333
    [15]
    VON KIETZELL K, POZZUTO T, HEILBRONN R, et al. Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q[J]. J Virol, 2014, 88(14): 8102-8115. doi: 10.1128/JVI.00649-14
  • Related Articles

    [1]WANG Zihan, CHEN Xin, ZHANG Botao, KANG Ran, ZHU Yao. Drug use rules in cervical spondylosis of nerve root with qi stagnation and blood stasis syndrome based on data mining[J]. Journal of Clinical Medicine in Practice, 2023, 27(17): 110-116. DOI: 10.7619/jcmp.20231679
    [2]CHEN Danhua, GE Xufeng, CHENG Hongbing, LU Rong, MA Fengfeng. Clinical application of zero-profile anchored spacer in anterior cervical discectomy and fusion[J]. Journal of Clinical Medicine in Practice, 2020, 24(1): 32-35. DOI: 10.7619/jcmp.202001008
    [3]BAI Zhangyong, LI Wenjie. Efficiency analysis of spinal traction, Jingtong Granule as well as acupuncture and moxibustion in treatment of patients with cervical spondylotic radiculopathy[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 84-87. DOI: 10.7619/jcmp.201920023
    [4]ZHANG Bo. Clinical observation on acupuncture on neck acupoints in treatment of vertebral artery type cervical spondylopathy[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 55-56.
    [5]TIAN Shuchun. Effect observation of traction, external application of Chinese drugs combined with massage on the treatment of patients with sympathetic cervical spondylosis[J]. Journal of Clinical Medicine in Practice, 2015, (13): 37-39. DOI: 10.7619/jcmp.201513011
    [6]HU Zhaobin, FU Qiang. Effects of Tongluo Dingxuan decoction on hemorheology, ET, NO of rabbits with vertebral artery type cervical spondylosis[J]. Journal of Clinical Medicine in Practice, 2013, (15): 1-4. DOI: 10.7619/jcmp.201315001
    [7]ZHANG Li, XIA Qing, YE Yaling, GENG Mengqi, WANG Qian. Application of comprehensive rehabilitation nursing in treatment of cervical spondylosis[J]. Journal of Clinical Medicine in Practice, 2012, (20): 67-69.
    [8]LI Zhi-gang, LI Feng. Effects of Methylprednisolone on Protecting Spinal Cord During Cervical Spondylotic Myelopathy Operation[J]. Journal of Clinical Medicine in Practice, 2007, (3): 47-49. DOI: 10.3969/j.issn.1672-2353.2007.03.013
    [9]Treating cervical spondylosis and herniated cervical disc with ozon therapy: A report of 37 cases[J]. Journal of Clinical Medicine in Practice, 2007, (1): 14-15,25. DOI: 10.3969/j.issn.1672-2353.2007.01.004
    [10]JIAO Xiu-ping, ZHOU Qiao-ling. Nursing of frontpass spinal operation of cervical sondylosis[J]. Journal of Clinical Medicine in Practice, 2005, (4): 36-37. DOI: 10.3969/j.issn.1672-2353.2005.04.019
  • Cited by

    Periodical cited type(5)

    1. 木国法,李旭,龚应玲. 白细胞介素-4、瘦素、趋化素与肥胖型哮喘患儿病情程度的关系及预测哮喘控制的价值. 实用临床医药杂志. 2025(03): 108-113 . 本站查看
    2. 杨洁. 儿保门诊小儿骨密度检测结果分析及干预. 婚育与健康. 2024(06): 97-99 .
    3. 高诗宇,吴力群,马佳,李盼盼,路晨,聂力. 基于网络药理学和分子对接技术探讨缓哮六安煎治疗儿童支气管哮喘的作用机制. 现代中西医结合杂志. 2022(11): 1513-1520 .
    4. 陈春娟,蔡剑英,刘凤林. 吸入性糖皮质激素长期低剂量应用对轻中度支气管哮喘儿童生长发育的影响分析. 贵州医药. 2022(10): 1574-1575 .
    5. 安家,李霞,李虹霖,杜淑玲. 小儿咳嗽变异性哮喘患儿骨代谢指标水平及其临床意义. 系统医学. 2022(21): 1-5 .

    Other cited types(0)

Catalog

    Article views (528) PDF downloads (41) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return